Literature DB >> 26575788

Generation of a KOR-Cre knockin mouse strain to study cells involved in kappa opioid signaling.

Xiaoyun Cai1, Huizhen Huang1,2, Marissa S Kuzirian1, Lindsey M Snyder1, Megumi Matsushita3, Michael C Lee1, Carolyn Ferguson4, Gregg E Homanics4, Alison L Barth3, Sarah E Ross1.   

Abstract

The kappa opioid receptor (KOR) has numerous important roles in the nervous system including the modulation of mood, reward, pain, and itch. In addition, KOR is expressed in many non-neuronal tissues. However, the specific cell types that express KOR are poorly characterized. Here, we report the development of a KOR-Cre knockin allele, which provides genetic access to cells that express KOR. In this mouse, Cre recombinase (Cre) replaces the initial coding sequence of the Opkr1 gene (encoding the kappa opioid receptor). We demonstrate that the KOR-Cre allele mediates recombination by embryonic day 14.5 (E14.5). Within the brain, KOR-Cre shows expression in numerous areas including the cerebral cortex, nucleus accumbens and striatum. In addition, this allele is expressed in epithelium and throughout many regions of the body including the heart, lung, and liver. Finally, we reveal that KOR-Cre mediates recombination of a subset of bipolar and amacrine cells in the retina. Thus, the KOR-Cre mouse line is a valuable new tool for conditional gene manipulation to enable the study of KOR.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Cre-loxP system; KOPr; OPRK1; genetics; opioid

Mesh:

Substances:

Year:  2015        PMID: 26575788      PMCID: PMC4747253          DOI: 10.1002/dvg.22910

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  38 in total

1.  The therapeutic potential of κ-opioids for treatment of pain and addiction.

Authors:  Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2011-01       Impact factor: 7.853

2.  A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior.

Authors:  Eyal Vardy; J Elliott Robinson; Chia Li; Reid H J Olsen; Jeffrey F DiBerto; Patrick M Giguere; Flori M Sassano; Xi-Ping Huang; Hu Zhu; Daniel J Urban; Kate L White; Joseph E Rittiner; Nicole A Crowley; Kristen E Pleil; Christopher M Mazzone; Philip D Mosier; Juan Song; Thomas L Kash; C J Malanga; Michael J Krashes; Bryan L Roth
Journal:  Neuron       Date:  2015-04-30       Impact factor: 17.173

3.  The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids.

Authors:  U Arvidsson; M Riedl; S Chakrabarti; L Vulchanova; J H Lee; A H Nakano; X Lin; H H Loh; P Y Law; M W Wessendorf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

4.  A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex.

Authors:  Hiroki Taniguchi; Miao He; Priscilla Wu; Sangyong Kim; Raehum Paik; Ken Sugino; Duda Kvitsiani; Duda Kvitsani; Yu Fu; Jiangteng Lu; Ying Lin; Goichi Miyoshi; Yasuyuki Shima; Gord Fishell; Sacha B Nelson; Z Josh Huang
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

Review 5.  Opioids and cardioprotection.

Authors:  J E Schultz; G J Gross
Journal:  Pharmacol Ther       Date:  2001-02       Impact factor: 12.310

Review 6.  κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction.

Authors:  Eduardo R Butelman; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Trends Neurosci       Date:  2012-06-16       Impact factor: 13.837

7.  Opiate binding in rat hearts: modulation of binding after hemorrhagic shock.

Authors:  S A Krumins; A I Faden; G Feuerstein
Journal:  Biochem Biophys Res Commun       Date:  1985-02-28       Impact factor: 3.575

8.  Opioid receptor-activation: retina protected from ischemic injury.

Authors:  Shahid Husain; David E Potter; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

9.  Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.

Authors:  Charles Chavkin; Sumit Sud; Wenzhen Jin; Jeremy Stewart; Jordan K Zjawiony; Daniel J Siebert; Beth Ann Toth; Sandra J Hufeisen; Bryan L Roth
Journal:  J Pharmacol Exp Ther       Date:  2004-01-08       Impact factor: 4.030

Review 10.  The kappa opioid receptor: from addiction to depression, and back.

Authors:  Laurence Lalanne; Gulebru Ayranci; Brigitte L Kieffer; Pierre-Eric Lutz
Journal:  Front Psychiatry       Date:  2014-12-08       Impact factor: 4.157

View more
  10 in total

1.  Kappa Opioid Receptor Distribution and Function in Primary Afferents.

Authors:  Lindsey M Snyder; Michael C Chiang; Emanuel Loeza-Alcocer; Yu Omori; Junichi Hachisuka; Tayler D Sheahan; Jenna R Gale; Peter C Adelman; Elizabeth I Sypek; Stephanie A Fulton; Robert L Friedman; Margaret C Wright; Melissa Giraldo Duque; Yeon Sun Lee; Zeyu Hu; Huizhen Huang; Xiaoyun Cai; Kimberly A Meerschaert; Vidhya Nagarajan; Toshiro Hirai; Gregory Scherrer; Daniel H Kaplan; Frank Porreca; Brian M Davis; Michael S Gold; H Richard Koerber; Sarah E Ross
Journal:  Neuron       Date:  2018-09-19       Impact factor: 17.173

2.  Synergy of Distinct Dopamine Projection Populations in Behavioral Reinforcement.

Authors:  Gabriel Heymann; Yong S Jo; Kathryn L Reichard; Naomi McFarland; Charles Chavkin; Richard D Palmiter; Marta E Soden; Larry S Zweifel
Journal:  Neuron       Date:  2019-12-23       Impact factor: 17.173

Review 3.  Endogenous Opioid Dynorphin Is a Potential Link between Traumatic Brain Injury, Chronic Pain, and Substance Use Disorder.

Authors:  Kaitlin M Best; Marissa M Mojena; Gordon A Barr; Heath D Schmidt; Akiva S Cohen
Journal:  J Neurotrauma       Date:  2022-01       Impact factor: 4.869

4.  Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.

Authors:  Joshua D Gross; Shane W Kaski; Karl T Schmidt; Elizabeth S Cogan; Kristen M Boyt; Kim Wix; Adam B Schroer; Zoe A McElligott; David P Siderovski; Vincent Setola
Journal:  Neuropsychopharmacology       Date:  2019-05-29       Impact factor: 7.853

5.  The Paraventricular Hypothalamus Regulates Satiety and Prevents Obesity via Two Genetically Distinct Circuits.

Authors:  Monica M Li; Joseph C Madara; Jennifer S Steger; Michael J Krashes; Nina Balthasar; John N Campbell; Jon M Resch; Nicholas J Conley; Alastair S Garfield; Bradford B Lowell
Journal:  Neuron       Date:  2019-03-14       Impact factor: 17.173

6.  Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function.

Authors:  Catherine Cahill; Hugo A Tejeda; Mariana Spetea; Chongguang Chen; Lee-Yuan Liu-Chen
Journal:  Handb Exp Pharmacol       Date:  2022

7.  Targeting Morphine-Responsive Neurons: Generation of a Knock-In Mouse Line Expressing Cre Recombinase from the Mu-Opioid Receptor Gene Locus.

Authors:  Julie Bailly; Natalie Del Rossi; Léonie Runtz; Jing-Jing Li; DaWoon Park; Grégory Scherrer; Arnaud Tanti; Marie-Christine Birling; Emmanuel Darcq; Brigitte L Kieffer
Journal:  eNeuro       Date:  2020-05-29

Review 8.  Recent advances in basic science methodology to evaluate opioid safety profiles and to understand opioid activities.

Authors:  Aliza T Ehrlich; Emmanuel Darcq
Journal:  Fac Rev       Date:  2021-02-19

Review 9.  Knock-In Mouse Models to Investigate the Functions of Opioid Receptors in vivo.

Authors:  Jade Degrandmaison; Samuel Rochon-Haché; Jean-Luc Parent; Louis Gendron
Journal:  Front Cell Neurosci       Date:  2022-01-31       Impact factor: 5.505

10.  Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors?

Authors:  Caroline M Kopruszinski; Robson Vizin; Moe Watanabe; Ashley L Martinez; Luiz Henrique Moreira de Souza; David W Dodick; Frank Porreca; Edita Navratilova
Journal:  J Headache Pain       Date:  2022-09-30       Impact factor: 8.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.